Items 121 to 130 of 176 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
N-Formyl-Met-Leu-Phe-Lys | 104180-18-9 | sc-391160 sc-391160A | 1 mg 10 mg | $60.00 $278.00 | ||
N-Formyl-Met-Leu-Phe-Lys is a peptide that showcases distinctive interactions with cellular receptors, influencing signaling pathways related to immune response and cellular communication. Its formylation enhances its affinity for specific receptors, promoting unique conformational dynamics that facilitate receptor activation. The compound's stability against proteolytic enzymes allows for prolonged biological activity, making it a subject of interest in studies of peptide behavior and receptor modulation. | ||||||
[Pro9] Substance P | 104486-69-3 | sc-396074 sc-396074A | 500 µg 2.5 mg | $75.00 $188.00 | ||
Substance P is a neuropeptide that plays a crucial role in transmitting pain signals and modulating inflammatory responses. Its unique structure allows for specific binding to neurokinin receptors, triggering a cascade of intracellular signaling pathways. This interaction influences neurotransmitter release and alters cellular excitability. Additionally, Substance P exhibits a high degree of stability in physiological conditions, enabling sustained effects on neuronal communication and sensory perception. | ||||||
Glucagon-Like Peptide 1 (7-36) Amide | 107444-51-9 | sc-391162 | 1 mg | $369.00 | ||
Glucagon-Like Peptide 1 (7-36) Amide is a biologically active peptide that primarily influences glucose metabolism and appetite regulation. Its unique sequence facilitates binding to the GLP-1 receptor, initiating a series of intracellular signaling events that enhance insulin secretion and inhibit glucagon release. This peptide exhibits a rapid degradation profile, influenced by enzymatic activity, which underscores its transient yet potent effects on metabolic pathways. Its interactions also promote β-cell proliferation, contributing to overall metabolic homeostasis. | ||||||
BNP (1-32), human | 114471-18-0 | sc-391192 sc-391192A | 500 µg 1 mg | $360.00 $600.00 | ||
BNP (1-32) is a biologically active peptide that plays a crucial role in cardiovascular homeostasis. It binds specifically to the natriuretic peptide receptor, triggering guanylate cyclase activity and increasing intracellular cGMP levels. This cascade leads to vasodilation and natriuresis, effectively regulating blood pressure and fluid balance. BNP (1-32) exhibits a rapid clearance from circulation, highlighting its dynamic role in acute physiological responses. Its unique structure allows for specific receptor interactions, influencing cardiac function and vascular tone. | ||||||
Deltorphin I | 122752-15-2 | sc-396073 | 1 mg | $85.00 | 1 | |
Deltorphin I is a potent endogenous peptide that selectively binds to delta-opioid receptors, initiating a cascade of intracellular signaling pathways. This interaction enhances the release of neurotransmitters, modulating pain perception and emotional responses. Deltorphin I exhibits high affinity and specificity, leading to distinct receptor conformations that influence downstream effects. Its rapid degradation in biological systems underscores its role in transient signaling events, contributing to the fine-tuning of nociceptive pathways. | ||||||
PACAP(6-38) | 137061-48-4 | sc-391136 sc-391136A | 500 µg 1 mg | $529.00 $914.00 | ||
PACAP(6-38) is a biologically active peptide fragment that plays a crucial role in modulating neuroendocrine functions. Its unique sequence allows for selective binding to specific receptors, triggering distinct intracellular signaling pathways. The compound exhibits a high affinity for G-protein coupled receptors, influencing calcium signaling and cyclic AMP production. Its conformational flexibility enhances interactions with various biomolecules, impacting cellular responses and communication. Additionally, PACAP(6-38) demonstrates stability in physiological conditions, facilitating its role in neurobiological processes. | ||||||
1-Alaninechlamydocin | 141446-96-0 | sc-391717 | 500 µg | $204.00 | ||
1-Alaninechlamydocin is a biologically active compound characterized by its ability to selectively interact with target proteins, influencing enzymatic activity and metabolic pathways. Its unique structure allows for specific hydrogen bonding and hydrophobic interactions, enhancing its binding affinity. The compound exhibits notable reaction kinetics, facilitating rapid cellular uptake and modulation of intracellular processes. Its stability under physiological conditions supports its role in various biological systems, impacting cellular signaling and function. | ||||||
Mas7 | 145854-59-7 | sc-396179 | 1 mg | $180.00 | ||
Mas7 is a biologically active compound distinguished by its capacity to modulate protein-protein interactions, thereby influencing cellular signaling cascades. Its unique functional groups enable specific electrostatic interactions and conformational changes in target proteins, enhancing selectivity. The compound demonstrates intriguing reaction kinetics, promoting efficient cellular localization and bioavailability. Additionally, its robust stability in diverse environments allows it to effectively engage in complex biological networks, impacting various physiological processes. | ||||||
Siamycin I | 164802-68-0 | sc-396543 | 250 µg | $104.00 | ||
Siamycin I is a biologically active compound known for its ability to disrupt cellular homeostasis through targeted inhibition of key enzymatic pathways. Its unique structural features facilitate strong binding affinities to specific receptors, leading to altered gene expression profiles. The compound exhibits remarkable selectivity due to its capacity to form transient complexes, influencing downstream signaling events. Furthermore, its dynamic interactions with cellular membranes enhance its penetration and distribution within biological systems. | ||||||
Cathepsin L inhibitor | 167498-29-5 | sc-3132 | 5 mg | $122.00 | 15 | |
Cathepsin L inhibitor is a biologically active compound characterized by its selective modulation of proteolytic activity within cellular environments. Its unique binding dynamics allow for the formation of stable enzyme-inhibitor complexes, effectively altering protease activity and influencing cellular degradation pathways. The inhibitor's specificity is enhanced by its ability to interact with distinct active site residues, leading to a nuanced regulation of protein turnover and cellular signaling cascades. |